ALPL Gene: Alkaline Phosphatase, Liver/Bone/Kidney

Genetic and functional insights into ALPL, its role in hypophosphatasia, and clinical significance.

Gene Information Card

Symbol ALPL
Full Name Alkaline Phosphatase, Biomineralization Associated
Gene Type Protein coding
Chromosomal Location 1p36.12
NCBI Gene ID 249 ncbi.nlm.nih.gov/gene/249
Ensembl ID ENSG00000162551
UniProt ID P05186
OMIM ID 171760
HGNC ID 438
Aliases TNSALP, AP-TNAP, HOPS, TNAP

Description

The ALPL gene encodes tissue-nonspecific alkaline phosphatase (TNSALP), a membrane-bound enzyme that hydrolyzes pyrophosphate, pyridoxal-5'-phosphate, and other phosphocompounds. It is essential for bone mineralization and is expressed primarily in liver, bone, and kidney. Loss-of-function mutations cause hypophosphatasia (HPP), a disorder characterized by defective skeletal mineralization.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypophosphatasia (HPP) Loss-of-function mutations reduce TNSALP activity, leading to accumulation of inorganic pyrophosphate (PPi), an inhibitor of hydroxyapatite crystal formation, impairing bone and tooth mineralization. ClinVar, OMIM
Odontohypophosphatasia Mild ALPL mutations cause premature tooth loss and dental defects without systemic skeletal disease. ClinVar, OMIM
Infantile Hypophosphatasia Severe ALPL mutations (e.g., homozygous or compound heterozygous) result in profound skeletal hypomineralization, respiratory failure, and high mortality. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Bone (osteoblasts) 8.3 Medium
Kidney 6.1 Low
Small intestine 2.0 Low
Placenta 1.5 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 15.2 High expression
Saos-2 (osteosarcoma) 10.8 High expression
HEK293 (embryonic kidney) 4.5 Moderate expression
MCF7 (breast) 0.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.571G>A (p.Glu191Lys) Missense Common in European HPP Loss of function
c.979T>C (p.Phe327Leu) Missense ~5% in HPP Loss of function
c.346G>A (p.Ala116Thr) Missense ~3% in HPP Loss of function
c.1559delT (p.Leu520Trpfs*86) Frameshift Rare Loss of function
Mutation functional classification

Loss of Function (LOF)

Most ALPL mutations are loss-of-function, reducing TNSALP enzymatic activity, leading to pyrophosphate accumulation and impaired bone mineralization.

Gain of Function (GOF)

No gain-of-function mutations are clinically reported for ALPL.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects in heterozygous carriers, but autosomal recessive inheritance is typical.

Gene Ontology (GO)

• GO:0004035 – alkaline phosphatase activity • GO:0005576 – extracellular region
• GO:0005886 – plasma membrane • GO:0001503 – ossification
• GO:0046849 – bone mineralization

Pathways

Pyridoxal phosphate salvage pathway
Phosphate metabolism
Bone mineralization (Reactome: R-HSA-1474228)

Protein Summary

Tissue-nonspecific alkaline phosphatase (TNSALP) is a 524-amino-acid glycoprotein anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor. It functions as a homodimer, requiring zinc and magnesium ions for catalytic activity. TNSALP dephosphorylates substrates such as inorganic pyrophosphate (PPi) and pyridoxal-5'-phosphate (PLP), regulating bone mineralization and vitamin B6 metabolism.

Related Products

Product name Cat.No. Species Gene ID
ALPL Knockout HEK293 Cell Line EDC08024 Human 249 Details Get a Quote
ALPL Knockout HeLa Cell Line EDJ-KQ22028 Human 249 Details Get a Quote
ALPL Knockout A-549 Cell Line EDJ-KQ61079 Human 249 Details Get a Quote
ALPL Knockout HCT 116 Cell Line EDJ-KQ69561 Human 249 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: